Amy Gee, MD
Urogynecology and Reconstructive Pelvic Surgery · Cleveland, OHNPI 1760915060
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,832 of the $5,104 with a category attached, or 75.1%. 8 manufacturers reported payments, led by Axonics, Inc. at 40.1% of the total. Reporting peaked in 2024 at $3,141 and has fallen 83.4% since, to $522 in 2025.
Across 56 payments — averaging $91.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Boston Scientific$2K
- Caldera Medical, Inc$353
- Coloplast$319
- AbbVie$253
- Medtronic$178
- plus $152 from 2 others
What the payments were for
- Travel & lodging$1,09021%
- Food & beverage$3,83275%
- Education$1834%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 19 | $2,045 |
| Boston Scientific | 18 | $1,804 |
| Caldera Medical, Inc | 3 | $353 |
| Coloplast | 4 | $319 |
| AbbVie | 7 | $253 |
| Medtronic | 3 | $178 |
| Intuitive Surgical | 1 | $115 |
| Applied Medical Resources Corporation | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,898
- Bulkamid$1,305
- Advantage System$659
- Solyx SIS System$528
- UPSYLON$264
- Desara$170
- ALTIS$167
- BOTOX$123
- Da Vinci Surgical System$115
- INTERSTIM$114
How this compares
$5,104 in reported general payments places this provider in the 60th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
See all urogynecology and reconstructive pelvic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 18 | $9,495 |
| MyrbetriqMirabegron | 20 | $9,226 |
| Estradiol | 41 | $3,196 |
| Trospium Chloride ErTrospium Chloride | 11 | $761 |
| Solifenacin Succinate | 12 | $333 |
| Cephalexin | 50 | $323 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $181 |
| Ibuprofen | 17 | $47 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $46 |
| Oxycodone Hcl | 25 | $28 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Cleveland
- Emily SlopnickCleveland$37K
- Ly Hoang RobertsCleveland$23K
- Marie ParaisoCleveland$20K
- Omer AnisCleveland$17K
- Chen ShenharCleveland$13K
- Amy ParkCleveland$11K
- Katie PropstCleveland$6K
- Anne SammarcoCleveland$5K
- Shannon WallaceCleveland$5K
- Graham ChapmanCleveland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.